Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Table 4 shows the [Hb], Ht, blood sugar, and serum profiles before the intervention; there were no significant differences between the two groups (all P > 0.170).Medication content in both groupsTypes of medicinesPG (n = 8)CG (n = 8)P valuesAntihypertensives Calcium blocker350.317α blocker010.302β blocker111.000ARB331.000Diuretics210.522Antithromboembolism Anticoagulants210.522 Antiplatelet agents560.590Antithyperlipidemia (HMG-CoA reductase inhibitor)55 1.000Antidiabetic drug20 0.131Osteoporosis drug (an analogue of vitamin D)54 0.614Analgesics NSAIDs020.131 Pregabalin221.000Antidepressant SNRI010.302 SSRI111.000 Nonbenzodiazepine111.000 Benzodiazepine130.248Gastric secretion inhibitor/ mucosal defense Proton pump inhibitor630.131 H2 receptor antagonist020.131 Gastric mucosal defense030.055Cardiorespiratory disease drugs Bronchodilator (β agonist)010.302 Antitussive010.302 Anti-allergic (antihistamine)100.302 Digitalis100.302Urologic disease drugs Anticholinergic agent100.302 β3 agonist010.302 Urinary tract antispasmodic010.302Others Laxative331.000 Thyroid hormone preparation100.302 Antihyperuricemic111.000 Acetylcholinesterase inhibitor111.000The numbers of medications in the intervention (PG) and control groups (CG) are shownARB, angiotensin II receptor blocker; HMG-CoA, 3-hydroxy-3-methylglutaryl-coenzyme A; NSAIDs, non-steroidal anti-inflammatory drug; SNRI, serotonin-noradrenaline reuptake inhibitor; SSRI, selective serotonin reuptake inhibitorThe P values of the χ2 test were describedHaemoglobin concentration, haematocrit, blood sugar, and serum profiles before and after the interventionMeasurementsPG (n = 8)CG (n = 8)P valuesBeforeAfterBeforeAfterTime GroupGroup × Time[Hb], g/dL12.6 (1.9)12.7 (2.2)13.0 (1.7)12.9 (1.9)0.7810.7530.734Haematocrit, %37.3 (5.6)37.9 (5.2)38.9 (4.5)39.0 (4.7)0.4150.5840.582[Albumin]s, g/dL4.1 (0.4)4.0 (0.2)4.4 (0.2)4.2 (0.3)0.1330.1360.862[Creatinine]s, mg/dL0.85 (0.27)0.87 (0.21)0.888C-reactive protein, mg/dL0.1 (0.2)0.3 (0.2)0.204Blood sugar, mg/dL121.8 (23.5)119.0 (21.0)0.809[Total cholesterol]s, mg/dL184.0 (32.8)188.0 (25.7)0.790[Triglycerides]s, mg/dL210.1 (77.0)204.0 (132.0)0.911Data are median values (SD) in the intervention (PG) and control groups (CG)[Hb], haemoglobin concentration; []s, serum concentration of each relevant item.
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Double-blind reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Four patients had mild anaemia and one patient had moderate anaemia []; however, all 5 patients were included in the study.
Source: Methods.
This was a preliminary prospective intervention, and a double-blind study involving one patient from each group who performed both trials, after a wash-out period of 5 or 6 months.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Three-week exercise and protein intake immediately after exercise increases the 6-min walking distance with simultaneously improved plasma volume in patients with chronic cerebrovascular disease: a preliminary prospective study
Study design awaiting verification · BMC Sports Science, Medicine and Rehabilitation · 2022
Original publication title
Three-week exercise and protein intake immediately after exercise increases the 6-min walking distance with simultaneously improved plasma volume in patients with chronic cerebrovascular disease: a preliminary prospective study
© The Author(s) 2022
Original publication · Publisher record · CC BY 4.0 · CC0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Blood volume (BV) is a critical factor for physical endurance in chronic stroke patients, while hypervolemia can worsen hypertension in these patients. This prospective study assessed whether rehabilitation combined with protein supplementation immediately after each exercise for 3 weeks would improve plasma volume (PV) and BV as well as physical endurance without worsening hypertension.
Source: BackgroundAbstract: What methods does the paper describe?
Ambulatory patients with chronic cerebrovascular disease who received a 3-week rehabilitation program with high protein jelly (intervention group [PG]; n = 8; 10-g protein) or protein-free jelly (control group [CG]; n = 8) consumed within 30 min after each exercise. PV and BV were assessed while measuring the 6-min walking distance (6MWD), peak oxygen consumption (VO2peak), strength of knee extension, and resting blood pressure before and after the intervention. Two-way ANOVA was used to determine whether there was an interaction of time × group.
The difference between before and after intervention or between the groups by post-hoc test (Tukey’s test) at the level of P < 0.05.
Source: MethodsAbstract: Results
The 6MWD increased only in the PG (P = 0.001; an interaction of Group and Time, P = 0.037). PV and BV increased only in the PG (P < 0.05). VO2peak and strength of knee extension in the paralysed limb increased in both groups (P < 0.05). The resting blood pressure did not worsen after the intervention.
Source: ResultsAbstract: Conclusions
In chronic post-stroke patients, 3-week rehabilitation combined with protein intake immediately after exercise increased 6MWD simultaneously with increased PV and BV, but it did not increase resting blood pressure. The present regimen is acceptable and effective for ambulatory patients with chronic cerebrovascular disease.
Name of the registry Examining effects of protein supplementation on functional improvement during rehabilitation intervention in chronic stroke patients
Trial registration number UMIN000028009; date of registration: 30/06/2017. This study was registered prospectively.
Source: Conclusions Source: Conclusions Source: ConclusionsAuthors’ abstract
Background
Blood volume (BV) is a critical factor for physical endurance in chronic stroke patients, while hypervolemia can worsen hypertension in these patients. This prospective study assessed whether rehabilitation combined with protein supplementation immediately after each exercise for 3 weeks would improve plasma volume (PV) and BV as well as physical endurance without worsening hypertension.
Methods
Ambulatory patients with chronic cerebrovascular disease who received a 3-week rehabilitation program with high protein jelly (intervention group [PG]; n = 8; 10-g protein) or protein-free jelly (control group [CG]; n = 8) consumed within 30 min after each exercise. PV and BV were assessed while measuring the 6-min walking distance (6MWD), peak oxygen consumption (VO2peak), strength of knee extension, and resting blood pressure before and after the intervention. Two-way ANOVA was used to determine whether there was an interaction of time × group.
The difference between before and after intervention or between the groups by post-hoc test (Tukey’s test) at the level of P < 0.05.
Results
The 6MWD increased only in the PG (P = 0.001; an interaction of Group and Time, P = 0.037). PV and BV increased only in the PG (P < 0.05). VO2peak and strength of knee extension in the paralysed limb increased in both groups (P < 0.05). The resting blood pressure did not worsen after the intervention.
Conclusions
In chronic post-stroke patients, 3-week rehabilitation combined with protein intake immediately after exercise increased 6MWD simultaneously with increased PV and BV, but it did not increase resting blood pressure. The present regimen is acceptable and effective for ambulatory patients with chronic cerebrovascular disease.
Name of the registry Examining effects of protein supplementation on functional improvement during rehabilitation intervention in chronic stroke patients
Trial registration number UMIN000028009; date of registration: 30/06/2017. This study was registered prospectively.
Supplementary Information
The online version contains supplementary material available at 10.1186/s13102-022-00429-x.
Publication and source details
Original title: Three-week exercise and protein intake immediately after exercise increases the 6-min walking distance with simultaneously improved plasma volume in patients with chronic cerebrovascular disease: a preliminary prospective study
Chika Sato; Yoshi-ichiro Kamijo; Yuta Sakurai; Shohei Araki; Yuki Sakata; Ayana Ishigame; Kota Murai; Izumi Yoshioka; Fumihiro Tajima
BMC Sports Science, Medicine and Rehabilitation · 2022
© The Author(s) 2022https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.the nachi-katsuura research foundationL1221Tajima Fumihiro Grants-in-Aid for Scientific Research21K11364Kamijo Yoshi-ichiroRepository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T09:53:43.546925+00:00
DOI: 10.1186/s13102-022-00429-x · PMC8922777